JP2016196511A5 - - Google Patents

Download PDF

Info

Publication number
JP2016196511A5
JP2016196511A5 JP2016163544A JP2016163544A JP2016196511A5 JP 2016196511 A5 JP2016196511 A5 JP 2016196511A5 JP 2016163544 A JP2016163544 A JP 2016163544A JP 2016163544 A JP2016163544 A JP 2016163544A JP 2016196511 A5 JP2016196511 A5 JP 2016196511A5
Authority
JP
Japan
Prior art keywords
dosage form
pharmaceutical dosage
phenylephrine
ketorolac
buffer system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016163544A
Other languages
English (en)
Japanese (ja)
Other versions
JP6282699B2 (ja
JP2016196511A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016196511A publication Critical patent/JP2016196511A/ja
Publication of JP2016196511A5 publication Critical patent/JP2016196511A5/ja
Application granted granted Critical
Publication of JP6282699B2 publication Critical patent/JP6282699B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016163544A 2012-10-24 2016-08-24 安定で保存剤非含有の散瞳および抗炎症注射用液剤 Active JP6282699B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261718026P 2012-10-24 2012-10-24
US61/718,026 2012-10-24
US201261736179P 2012-12-12 2012-12-12
US61/736,179 2012-12-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015539749A Division JP6017053B2 (ja) 2012-10-24 2013-10-23 安定で保存剤非含有の散瞳および抗炎症注射用液剤

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2016208082A Division JP2017014294A (ja) 2012-10-24 2016-10-24 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2018002514A Division JP2018058905A (ja) 2012-10-24 2018-01-11 安定で保存剤非含有の散瞳および抗炎症注射用液剤

Publications (3)

Publication Number Publication Date
JP2016196511A JP2016196511A (ja) 2016-11-24
JP2016196511A5 true JP2016196511A5 (enExample) 2017-01-05
JP6282699B2 JP6282699B2 (ja) 2018-02-21

Family

ID=50545210

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2015539749A Active JP6017053B2 (ja) 2012-10-24 2013-10-23 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2016163544A Active JP6282699B2 (ja) 2012-10-24 2016-08-24 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2016208082A Pending JP2017014294A (ja) 2012-10-24 2016-10-24 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2018002514A Withdrawn JP2018058905A (ja) 2012-10-24 2018-01-11 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2019036146A Withdrawn JP2019081798A (ja) 2012-10-24 2019-02-28 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2020104619A Withdrawn JP2020147606A (ja) 2012-10-24 2020-06-17 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2023012804A Withdrawn JP2023041804A (ja) 2012-10-24 2023-01-31 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2024207997A Pending JP2025019330A (ja) 2012-10-24 2024-11-29 安定で保存剤非含有の散瞳および抗炎症注射用液剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015539749A Active JP6017053B2 (ja) 2012-10-24 2013-10-23 安定で保存剤非含有の散瞳および抗炎症注射用液剤

Family Applications After (6)

Application Number Title Priority Date Filing Date
JP2016208082A Pending JP2017014294A (ja) 2012-10-24 2016-10-24 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2018002514A Withdrawn JP2018058905A (ja) 2012-10-24 2018-01-11 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2019036146A Withdrawn JP2019081798A (ja) 2012-10-24 2019-02-28 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2020104619A Withdrawn JP2020147606A (ja) 2012-10-24 2020-06-17 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2023012804A Withdrawn JP2023041804A (ja) 2012-10-24 2023-01-31 安定で保存剤非含有の散瞳および抗炎症注射用液剤
JP2024207997A Pending JP2025019330A (ja) 2012-10-24 2024-11-29 安定で保存剤非含有の散瞳および抗炎症注射用液剤

Country Status (39)

Country Link
US (6) US9066856B2 (enExample)
EP (2) EP2911511B1 (enExample)
JP (8) JP6017053B2 (enExample)
KR (4) KR101808394B1 (enExample)
CN (2) CN108721210A (enExample)
AP (1) AP2015008459A0 (enExample)
AR (1) AR093115A1 (enExample)
AU (1) AU2013201465B2 (enExample)
BR (1) BR112015009228B1 (enExample)
CA (1) CA2887772C (enExample)
CL (1) CL2015001078A1 (enExample)
CR (1) CR20150233A (enExample)
CU (1) CU20150037A7 (enExample)
CY (1) CY1124481T1 (enExample)
DK (1) DK2911511T3 (enExample)
EA (1) EA033811B1 (enExample)
ES (2) ES3040229T3 (enExample)
GE (1) GEP20186891B (enExample)
HR (1) HRP20210980T1 (enExample)
HU (1) HUE055537T2 (enExample)
IL (1) IL238439B2 (enExample)
IN (1) IN2015DN03029A (enExample)
LT (1) LT2911511T (enExample)
MA (1) MA38096B1 (enExample)
MD (1) MD20150050A2 (enExample)
MX (2) MX382411B (enExample)
MY (2) MY188474A (enExample)
NZ (1) NZ628398A (enExample)
PE (1) PE20150958A1 (enExample)
PH (1) PH12015500850B1 (enExample)
PL (1) PL2911511T3 (enExample)
PT (1) PT2911511T (enExample)
RS (1) RS62188B1 (enExample)
SG (1) SG11201502602WA (enExample)
SI (1) SI2911511T1 (enExample)
SM (1) SMT202100393T1 (enExample)
UA (1) UA114650C2 (enExample)
WO (1) WO2014066485A1 (enExample)
ZA (1) ZA201502684B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1534313E (pt) 2002-07-30 2013-01-25 Omeros Corp Soluções e método de irrigação oftalmológica
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US20210346318A1 (en) * 2013-10-03 2021-11-11 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
BR112016007328A2 (pt) 2013-10-03 2017-08-01 Imprimis Pharmaceuticals Inc composições oftálmicas baseadas em epinefrina para administração intraocular e métodos para fabricar as mesmas
TWI809304B (zh) * 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
CN104856990A (zh) * 2015-05-07 2015-08-26 武汉武药科技有限公司 去氧肾上腺素酮咯酸溶液及制备方法
US11213480B1 (en) * 2015-08-06 2022-01-04 Hikma Pharmaceuticals International Limited Phenylephrine hydrochloride ready-to-use solution
USD831868S1 (en) 2015-09-17 2018-10-23 Lume Cube, Inc. Compact external light
US10704745B2 (en) 2015-10-13 2020-07-07 Lume Cube, Inc. Mobile light source
EP3503873A4 (en) 2016-08-25 2020-04-15 Harrow IP, LLC EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHOD FOR THE PRODUCTION THEREOF
US20180318319A1 (en) * 2017-05-04 2018-11-08 Ocular Science, Inc. Compositions and Methods for Treating Eyes and Methods of Preparation
JP7078843B2 (ja) * 2018-03-26 2022-06-01 サミー株式会社 遊技機
BR112021007725A2 (pt) * 2018-10-26 2021-07-27 Ocuphire Pharma, Inc. métodos e composições para tratamento de presbiopia, midríase e outros distúrbios oculares
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
DE102019125430B3 (de) * 2019-09-20 2020-11-19 Carl Zeiss Meditec Ag Steuerungsvorrichtung für ein ophthalmochirurgisches System, ophthalmochirurgisches System sowie Computerprogrammprodukt
KR102749980B1 (ko) 2020-01-02 2025-01-03 삼성전자주식회사 에어 스페이서를 가지는 반도체 소자
WO2021150747A1 (en) * 2020-01-22 2021-07-29 Nevakar Inc. Phenylephrine hydrochloride compositions and containers
WO2022132567A1 (en) * 2020-12-17 2022-06-23 Harrow Ip, Llc Mydriatic compositions and methods for fabricating thereof
CN115368310B (zh) 2021-05-18 2025-06-27 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法
US12029729B2 (en) 2021-07-23 2024-07-09 Somerset Therapeutics, Llc Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof
US11696910B2 (en) 2021-07-23 2023-07-11 Somerset Therapeutics, Llc Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof
EP4604924A1 (en) * 2022-10-19 2025-08-27 Fresenius Kabi Austria GmbH Phenylephrine liquid formulations
CN115950992B (zh) * 2023-03-15 2023-06-09 苏州朗易生物医药研究有限公司 一种去氧肾上腺素酮咯酸溶液中有关物质的检测方法及其应用
WO2025165753A1 (en) * 2024-01-31 2025-08-07 Hikma Pharmaceuticals Usa Inc. Pharmaceutical formulations of phenylephrine and process of making the same

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4402949A (en) 1979-11-12 1983-09-06 Sandoz Ltd. Stable solutions of hydrogenated ergotalkaloids
US4550022A (en) 1981-10-05 1985-10-29 Alcon Laboratories, Inc. Tissue irrigating solution
JPS58126810A (ja) 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
US4474751A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
JPS6017053U (ja) 1983-07-11 1985-02-05 住友電気工業株式会社 伝送エラ−検出器
WO1987007141A1 (en) 1986-05-23 1987-12-03 New England Medical Center Hospitals, Inc. Method for treating glaucoma
US5212196A (en) 1986-10-21 1993-05-18 Alcon Laboratories, Inc. Control of post-surgical intraocular pressure using clonidine derivatives
US4938970A (en) 1987-02-06 1990-07-03 Hustead Robert E Painless electrolyte solutions
US5110493A (en) 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
US4876250A (en) 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
DE3833893A1 (de) 1988-10-05 1990-04-12 Bayer Ag Verwendung von basischen nitro-phenyl-dihydropyridin-amiden als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung ueber neue zwischenprodukte
US5036046A (en) 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
US5051443A (en) 1988-10-12 1991-09-24 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
US5371078A (en) 1988-10-31 1994-12-06 Alcon Laboratories, Inc. Angiostatic steroids and methods and compositions for controlling ocular hypertension
US5116868A (en) 1989-05-03 1992-05-26 The Johns Hopkins University Effective ophthalmic irrigation solution
CA2065375A1 (en) 1989-08-21 1991-02-22 Richard J. Sharpe Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
EP0502143B1 (en) 1990-09-07 1995-11-08 Universidad De Alicante Composition for treating ocular pain
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
IT1252692B (it) 1991-11-27 1995-06-23 Zambon Spa Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
WO1994008602A1 (en) * 1992-10-21 1994-04-28 Alcon Laboratories, Inc. Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery
US6117907A (en) 1993-04-14 2000-09-12 Sher; Neal A. Topical treatment of ocular pain after corneal surgery
JPH08503969A (ja) 1993-09-29 1996-04-30 アルコン ラボラトリーズ,インコーポレイテッド 増殖因子と組織形成抑制剤を含有する組成物
CA2149528A1 (en) 1993-09-29 1995-04-06 Billie M. York Compositions containing growth factors and antimetabolites
US5624893A (en) 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
CA2179147A1 (en) 1993-12-17 1995-06-22 Gerald D. Cagle Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
US6350781B1 (en) 1994-01-14 2002-02-26 Lee Shahinia, Jr. Method and analgesic preparations for sustained and extended corneal analgesia with subanesthetic concentrations of lidocaine
WO1995034298A1 (en) 1994-06-10 1995-12-21 Telor Ophthalmic Pharmaceuticals, Inc. Inhibition of intraoperative miosis/production of mydriasis by local anesthetics
US5523316A (en) 1994-06-23 1996-06-04 Alcon Laboratories, Inc. Intraocular irrigating solution containing agent for controlling IOP
WO1996019233A2 (en) 1994-12-12 1996-06-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
WO2000023061A2 (en) 1998-10-21 2000-04-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
JPH10510540A (ja) 1994-12-12 1998-10-13 オメロス メディカル システムズ,インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
KR100517210B1 (ko) 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
WO2000023066A2 (en) 1998-10-20 2000-04-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
US5767105A (en) 1995-05-03 1998-06-16 Peyman; Gholam A. Ocular solution
US5798356A (en) 1995-08-07 1998-08-25 Alcon Laboratories, Inc. Angiostatic compounds
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6413961B1 (en) 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US6280745B1 (en) 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
EP1039818A4 (en) 1996-07-26 2001-11-07 Schein Dental Equipment Co ARMREST MECHANISM FOR DENTAL ARMCHAIRS
GB9704352D0 (en) 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
US6030974A (en) 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
US5811446A (en) 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US6034256A (en) 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
US6495598B1 (en) 1997-04-22 2002-12-17 Ophtecs Corporation Perfusate preparation for ophthalmic operation
EP0903151A1 (en) 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
US6495529B1 (en) 1998-07-01 2002-12-17 Warner-Lambert Company (−)-Pseudoephedrine as a sympathomimetic drug
CN1114401C (zh) 1998-07-14 2003-07-16 阿尔康实验室公司 11-(3-二甲氨基亚丙基)-6,11-二氢二苯并[b,e]噁庚英-2-乙酸用于制药的新用途
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
FR2782721B1 (fr) 1998-09-01 2000-11-03 Inst Nat Sante Rech Med Nouveaux composes phosphohalohydrines, procede de fabrication et applications
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
EP1434573A2 (en) 1998-10-20 2004-07-07 Omeros Corporation Irrigation solution and method for inhibition of pain and inflammation
EP1261334A1 (en) 1998-10-20 2002-12-04 Omeros Corporation Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US20030087962A1 (en) 1998-10-20 2003-05-08 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
AU1345000A (en) 1998-11-05 2000-05-22 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
WO2000035433A2 (en) 1998-12-17 2000-06-22 Alcon Laboratories, Inc. Methods for the prevention and treatment of post-surgical complications
KR20010108296A (ko) * 1999-03-02 2001-12-07 출원후보충 눈의 질병을 치료 또는 예방하기 위한 유리체내 투여용 약제
BR0010546A (pt) 1999-05-14 2002-03-05 Univ California Terapia antiinflamatória para infecção mediada inflamatória
WO2001041550A2 (en) 1999-10-22 2001-06-14 Transdermatech, Inc. Topical anesthetic formulation
US6218428B1 (en) 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
EP1276475A2 (en) 2000-04-28 2003-01-22 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
PE20020146A1 (es) 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
WO2002005848A2 (en) 2000-07-13 2002-01-24 Pharmacia Corporation Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
KR20030023700A (ko) 2000-07-14 2003-03-19 알러간, 인코포레이티드 치료활성 성분을 함유하고 용해도가 증강된 조성물
CA2417489A1 (en) 2000-07-28 2002-02-07 Maria A. Peral Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
JP2002161032A (ja) 2000-09-14 2002-06-04 Taisho Pharmaceut Co Ltd 粘膜適用組成物
WO2002024191A1 (fr) 2000-09-20 2002-03-28 Yong Guang Pharmaceutical Co., Ltd. Medicament permettant de traiter et de prevenir la myopie
US20020183279A1 (en) 2001-04-18 2002-12-05 Koichiro Tanaka Pharmaceutical composition containing viscoelastic substance and medication
US20020198209A1 (en) 2001-05-03 2002-12-26 Allergan Sales Inc. Compositions having enhanced pharmacokinetic characteristics
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
PT1534313E (pt) * 2002-07-30 2013-01-25 Omeros Corp Soluções e método de irrigação oftalmológica
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
MX2007007613A (es) 2004-12-22 2007-08-03 Schering Corp Formulaciones farmaceuticas.
AU2005322305B2 (en) 2004-12-23 2010-09-16 Roxro Pharma, Inc. Therapeutic compositions for intranasal administration of ketorolac
FR2882930B1 (fr) 2005-03-09 2009-03-27 Walid Katib Nouvelles compositions ophtalmologiques et leur mode d'utilisation
DOP2007000055A (es) * 2006-04-10 2007-10-31 Senosiain S A De C V Lab Composición farmaceutica que comprende un analgésico y vitaminas
US20090258850A1 (en) 2007-08-21 2009-10-15 Frincke James M Stabilized therapeutic compositions and formulations
JP2011503061A (ja) 2007-11-08 2011-01-27 アーシエックス セラピューティックス, インコーポレイテッド 浸透圧活性剤及び血管収縮剤を含む眼けん腫脹の治療及び防止のための組成物
RU2600863C2 (ru) 2007-12-10 2016-10-27 Сентисс Фарма Прайвит Лимитед Офтальмическая композиция, включающая фенилэфрин
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
JP2012519712A (ja) * 2009-03-06 2012-08-30 メディミューン,エルエルシー ヒト化抗cd19抗体製剤
US8277781B2 (en) 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
MX2011013061A (es) * 2009-06-05 2012-02-28 Aciex Therapeutics Inc Formulaciones oftalmicas de fluticasona y metodos de uso.
MX2011013060A (es) * 2009-06-05 2012-02-28 Aciex Therapeutics Inc Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
US8680510B2 (en) 2010-06-28 2014-03-25 International Business Machines Corporation Method of forming compound semiconductor
EP2598119B1 (en) 2010-07-29 2018-09-19 Allergan, Inc. Preservative free brimonidine and timolol solutions
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI809304B (zh) 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液

Similar Documents

Publication Publication Date Title
JP2016196511A5 (enExample)
CO7111300A2 (es) Formulación de anticuerpos
PH12017500844B1 (en) Stable protein solution formulation containing high concentration of an anti-vegf antibody
JP2015078230A5 (enExample)
EA201200096A1 (ru) Фармацевтическая композиция ингибитора протеазы вируса гепатита c
EA201491285A1 (ru) Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
EA201490801A1 (ru) Композиции этанерцепта, стабилизированные комбинациями сахаров и полиолов
JOP20180025A1 (ar) مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
BR112014026493A2 (pt) derivados de imidazotiadiazol como inibidores do receptor ativado por protease 4 (par4) para tratar a agregação de plaqueta
SI2648520T1 (en) Dexmedetomidine premix formulation
FI3511004T3 (fi) Yhdistelmävalmisteita syövän hoitoon
EA201691490A1 (ru) Фармацевтическая композиция, содержащая бринзоламид
MX385518B (es) FORMULACIÓN QUE TIENE CARACTERÍSTICAS MEJORADAS DE LIBERACIÓN DE FÁRMACOS pH DEPENDIENTES, QUE CONTIENEN ESOMEPRAZOL O UNA DE SUS SALES FARMACÉUTICAS ACEPTABLE.
SA522431528B1 (ar) نواتج تجفيد/محاليل من بوليميكسين و زيدوفودين
AR090073A1 (es) N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos
PE20191550A1 (es) COMPOSICION FARMACEUTICA ACUOSA DE ANTICUERPO MONOCLONAL ANTI-TNFalfa RECOMBINANTE
AR095538A1 (es) Composiciones farmacéuticas de ésteres de testosterona de cadena larga lipoequilibrados para la administración oral
BR112014017058A2 (pt) formulações farmacêuticas estabilizadas de um potente inibidor de hcv
EA201691763A1 (ru) Стабильная быстрорастворимая лекарственная форма, содержащая амоксициллин и клавулановую кислоту
JP6854710B2 (ja) ペメトレキセドを含有する注射用溶液製剤
AR130115A2 (es) Formulación de solución de proteína estable que contiene alta concentración de un anticuerpo anti-vegf
AR102572A1 (es) Formulación de solución de proteína estable que contiene alta concentración de un anticuerpo anti-vegf
MX2016011522A (es) Composicion farmaceutica de esomeprazol con bicarbonato de sodio en el proceso de preparacion de una capsula, para el tratamiento de alopatias relacionadas con la acidez gastrica.
MX383557B (es) Formulaciones inyectables de paracetamol.
AR115293A1 (es) Composición farmacéutica para el tratamiento de la hipertensión arterial pulmonar